`______________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`______________________
`
`INTUITIVE SURGICAL, INC.,
`Petitioner,
`
`v.
`
`ETHICON LLC,
`Patent Owner.
`
`________________________
`
`Case IPR2019-00880
`U.S. Patent No. 7,490,749
`________________________
`
`PATENT OWNER’S UPDATED MANDATORY NOTICES
`PURSUANT TO 37 C.F.R. § 42.8
`
`
`
`Pursuant to 37 C.F.R. § 42.8(a)(3), Patent Owner Ethicon LLC submits
`
`the following updated mandatory notices.
`
`A. Real Party-In-Interest (37 C.F.R. § 42.8(b)(1)) - Unchanged
`
`Ethicon LLC (the assignee of U.S. Pat. No. 7,490,749 (“the 749 Patent”)) is
`
`an indirect subsidiary of Johnson & Johnson. Ethicon LLC has exclusively licensed
`
`Ethicon Endo-Surgery, Inc. to sell products in the United States that would infringe
`
`the 749 Patent absent a license. Ethicon Endo-Surgery, Inc. has exclusively
`
`sublicensed that right to Ethicon US, LLC. Ethicon US, LLC and Ethicon Endo-
`
`Surgery, Inc. are indirect subsidiaries of Johnson & Johnson.
`
`B. Related Matters (37 C.F.R. § 42.8(b)(2)) - Unchanged
`
`Patent Owner identifies the following judicial and/or administrative matters
`
`that may be deemed related under 37 C.F.R. § 42.8(b)(2):
`
`The 749 Patent is presently asserted in Ethicon LLC et al. v. Intuitive
`
`Surgical, Inc. et al., C.A. No. 1:18-cv-01325-LPS (D. Del.) (“the second Delaware
`
`litigation”). U.S. Pat. Nos. 9,844,369 (“the 369 Patent”), 8,602,288 (“the 288
`
`Patent”), 8,602,287 (“the 287 Patent”), and 9,326,770 (“the 770 Patent”) are also
`
`asserted in the second Delaware litigation. On March 12, 2019, Patent Owner filed
`
`a motion for leave to file an amended complaint in the second Delaware litigation to
`
`withdraw infringement allegations relating to the 770 Patent and assert two
`
`additional patents, U.S. Patent No. 9,844,379 (“the 379 Patent”) and U.S. Patent
`
`2
`
`
`
`No. 8,479,969 (“the 969 Patent”). On July 17, 2019, Patent Owner’s motion was
`
`denied without prejudice in light of the parties’ joint stipulation to stay the second
`
`Delaware litigation. The 969 Patent is also presently asserted in Ethicon LLC et al.
`
`v. Intuitive Surgical, Inc. et al., C.A. No. 1:17-cv-00871-LPS (D. Del.) (“the first
`
`Delaware litigation”).
`
`The 749 Patent is also presently asserted in Certain Reload Cartridges for
`
`Laparoscopic Surgical Staplers, Inv. No. 337-TA-1167 (USITC), along with U.S.
`
`Pat. No. 9,113,874 (“the 874 Patent”) and the 369, 379, and 969 Patents.
`
`No patents or applications claim priority to U.S. Patent Application No.
`
`11/729,355, which issued as the 749 Patent.
`
`The 749 Patent states that it is related to U.S. Patent Application No.
`
`11/729,013, filed Mar. 28, 2007 (the “013 Application”), now U.S. Patent No.
`
`8,056,787. No patents or applications claim priority to the 013 Application.
`
`The 749 Patent is subject to a terminal disclaimer tied to U.S. Patent
`
`Application No. 11/497937, filed Aug. 2, 2006 (the “937 Application”), now U.S.
`
`Patent No. 7,441,684. U.S. Patent No. 7,431,189 claims priority to the 937
`
`Application.
`
`C. Lead and Back-Up Counsel and Service Information (37 C.F.R. §
`42.8(b)(3)-(4)) - Updated
`
`3
`
`
`
`Patent Owner identifies the following lead and back-up counsel and service
`
`information:
`
`Lead Counsel
`Anish R. Desai
`Weil, Gotshal & Manges LLP
`767 Fifth Avenue
`New York, NY 10153
`T: 212-310-8730
`F: 212-310-8007
`anish.desai@weil.com
`USPTO Reg. No. 73,760
`Customer No. 506,499
`
`Back-Up Counsel
`Elizabeth Stotland Weiswasser
`Weil, Gotshal & Manges LLP
`767 Fifth Avenue
`New York, NY 10153
`T: 212-310-8022
`F: 212-310-8007
`elizabeth.weiswasser@weil.com
`USPTO Reg. No. 55,721
`
`Adrian Percer
`Weil, Gotshal & Manges LLP
`201 Redwood Shores, CA 94065
`T: 650-802-3141
`F: 650-802-3100
`adrian.percer@weil.com
`USPTO Reg. No. 46,986
`
`Christopher T. Marando
`Weil, Gotshal & Manges LLP
`2001 M Street, N.W., Suite 600
`Washington, D.C. 20036
`T: 202-682-7094
`F: 202-857-0940
`christopher.marando@weil.com
`USPTO Reg. No. 67,898
`
`Christopher M. Pepe
`Weil, Gotshal & Manges LLP
`2001 M Street, N.W., Suite 600
`Washington, D.C. 20036
`T: 202-682-7153
`F: 202-857-0940
`christopher.pepe@weil.com
`USPTO Reg. No. 73,851
`
`4
`
`
`
`Kathryn M. Kantha (Added)
`Weil, Gotshal & Manges LLP
`767 Fifth Avenue
`New York, NY 10153
`T: 212-310-8621
`F: 212-310-8007
`kathryn.kantha@weil.com
`USPTO Reg. No. 70,371
`
`Please address all correspondence to lead and backup counsel. Patent Owner
`
`consents to service by electronic mail at the following address:
`
`Ethicon.IPR.Service@weil.com.
`
`Date: January 14, 2020
`
` Respectfully submitted,
`
` 1
`
`/Anish R. Desai/
`Anish R. Desai
`Reg. No. 73,760
`Lead Counsel for Patent Owner
`
`5
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that on January 14, 2020, the foregoing
`
`PATENT OWNER’S UPDATED MANDATORY NOTICES PURSUANT TO
`
`37 C.F.R. § 42.8 was served via electronic mail, upon the following:
`
`Steven R. Katz
`Joshua A. Griswold
`Kenneth W. Darby, Jr.
`John C. Phillips
`Ryan P. O’Connor
`FISH & RICHARDSON
`3200 RBC Plaza, 60 South Sixth Street
`Minneapolis, MN 55402
`katz@fr.com
`griswold@fr.com
`kdarby@fr.com
`phillips@fr.com
`oconnor@fr.com
`
`IPR11030-0052IP1@fr.com
`PTABInbound@fr.com
`
` a
`
`/Kathy Shalabi/
`Kathy Shalabi
`IP Paralegal
`Weil, Gotshal & Manges LLP
`2001 M Street, N.W., Suite 600
`Washington, DC 20036
`T: 202-682-7085
`kathy.shalabi@weil.com
`
`6
`
`